This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kimura, H. Articles by Caturegli, P. Search for Related Content PubMed PubMed Citation Articles by Kimura, H. Articles by Caturegli, P.

Expression of Class II Major Histocompatibility Complex Molecules on Thyrocytes Does Not Cause Spontaneous Thyroiditis but Mildly Increases Its Severity after Immunization

Department of Pathology (H.K., M.K., S.-C.T., Y.-C.C., N.R.R., P.C.), The Johns Hopkins Medical Institutions, Baltimore, Maryland 21205; and Department of Microbiology (K.S.), Leprosy Research Center, National Institute of Infectious Diseases, Tokyo 189-0002, Japan

Address all correspondence and requests for reprints to: Patrizio Caturegli, M.D., M.P.H., Johns Hopkins Medical Institutions, Department of Pathology, Ross Building, Room 656, 720 Rutland Avenue, Baltimore, Maryland 21205. E-mail: pcat{at}jhmi.edu.

Class II major histocompatibility complex (MHC) molecules are classically expressed on antigen-presenting cells of the hematopoietic lineage but have also been described on epithelial cells in association with autoimmunity. In this context, however, it remains debatable whether class II MHC molecules are the initiating event or rather the consequence of the autoimmune attack. In addition, the role of epithelial class II expression once the autoimmune attack has begun is unknown. We generated transgenic mice expressing in the thyroid follicular cells the class II transactivator, the master regulator of all the genes in the class II MHC pathway. The study used a cohort of 245 CBA/J mice (127 wild-type and 118 transgenic), both in basal conditions (n = 63) and at different time points after immunization with mouse thyroglobulin (n = 182). In basal conditions, transgenic mice were similar to wild-type controls and did not develop spontaneous autoimmune thyroiditis, despite the aberrant expression of class II MHC molecules on thyrocytes. After immunization, thyroiditis was 8% more severe in transgenics than controls (95% confidence interval from 1.8–13.4%; P = 0.033), especially during the florid stages of disease. These findings suggest that expression of class II MHC molecules on epithelial cells is not sufficient to initiate autoimmunity but mildly modulates an already established autoimmune attack against the target organ.

This article has been cited by other articles:

				H. J. Kimura, R. Rocchi, M. A. Landek-Salgado, K. Suzuki, C. Y. Chen, M. Kimura, N. R. Rose, and P. Caturegli Influence of Signal Transducer and Activator of Transcription-1 Signaling on Thyroid Morphology and Function Endocrinology, July 1, 2009; 150(7): 3409 - 3416. [Abstract] [Full Text] [PDF]

				R. Arakaki, A. Nagaoka, N. Ishimaru, A. Yamada, S. Yoshida, and Y. Hayashi Role of Plasmacytoid Dendritic Cells for Aberrant Class II Expression in Exocrine Glands from Estrogen-Deficient Mice of Healthy Background Am. J. Pathol., May 1, 2009; 174(5): 1715 - 1724. [Abstract] [Full Text] [PDF]

				C. Y. Chen, H. Kimura, M. A. Landek-Salgado, J. Hagedorn, M. Kimura, K. Suzuki, W. Westra, N. R. Rose, and P. Caturegli Regenerative Potentials of the Murine Thyroid in Experimental Autoimmune Thyroiditis: Role of CD24 Endocrinology, January 1, 2009; 150(1): 492 - 499. [Abstract] [Full Text] [PDF]

				S.-C. Tzou, I. Lupi, M. Landek, A. Gutenberg, Y.-M. Tzou, H. Kimura, G. Pinna, N. R. Rose, and P. Caturegli Autoimmune Hypophysitis of SJL Mice: Clinical Insights from a New Animal Model Endocrinology, July 1, 2008; 149(7): 3461 - 3469. [Abstract] [Full Text] [PDF]